Trump and Fox News Are Suddenly Silent on Their “Miracle” Drug Hydroxychloroquine

Their reckless promotion flew in the face of expert warnings.

Yuri Gripas/ZUMA

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

After aggressively promoting an anti-malaria drug as a “miracle” in the fight against COVID-19—a push that flew in the face of repeated warnings from experts—President Donald Trump and Fox News personalities suddenly appear to be cooling on hydroxychloroquine just as a new study reports the drug could lead to a higher death rate.

“The fact of the matter is we don’t know,” Dr. Mehmet Oz told the hosts of Fox & Friends on Wednesday. “Thankfully these medications are prescriptions only… We are better off waiting for the randomized trials Dr. Fauci has been asking for.” 

The segment was a head-spinning reversal for Oz, who less than a week ago encouraged Americans to participate in an at-home hydroxychloroquine clinical trial. “They mail you the pills, you start the protocol, tell them what happened… Be part of the solution,” he told Fox News viewers in a segment on April 16, the latest in Oz’s ongoing promotion of hydroxychloroquine on the conservative news network.

The attempt to strike a more cautious approach this week comes on the heels of new studies that showed hydroxychloroquine yielded no benefit in helping patients infected with the virus; one study on US veterans reported more deaths among those treated with the drug than those who received normal care. 

When asked about the veterans’ study on Tuesday, Trump, perhaps the biggest hydroxychloroquine cheerleader of all, dodged.

“I don’t know of the report,” he said at his daily coronavirus briefing. “Obviously there have been some very good reports and perhaps this one’s not a good report. But we’ll be looking at it.”

The claim of ignorance appeared to track with what could be a retreat in Trump’s relentless hydroxychloroquine promotion. Politico reports that the president has significantly reduced his mentions of the drug in recent days, both in his coronavirus pressers and social media, as he shifts his focus to promoting open rebellion of Democratic governors over lockdown restrictions. Still, his repeated claims that hydroxychloroquine could be a “miracle” are unlikely to be forgotten.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate